A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, and to Explore the Effect of Food After Multiple Doses of Selected Prototypes in Healthy Adult Participants

NCT07063342 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Xanomeline/Trospium Chloride Capsule
DRUG: Xanomeline Enteric Capsule
DRUG: Trospium Chloride

Sponsor

Bristol-Myers Squibb